Navigation Links
Apricoxib Prolongs Time-to-Progression and Overall Survival in Biomarker-Selected NSCLC Patients
Date:6/6/2011

II randomized trial of apricoxib in combination with erlotinib and gemcitabine for the first-line treatment of patients with pancreatic cancer.

About Capoxigem® (apricoxib, TG01)

Capoxigem (apricoxib, TG01) is an oral, once-daily selective COX-2 inhibitor. It is being evaluated for the treatment of cancer. Capoxigem affects a number of different oncogenic signaling pathways, including the HIF-1, VEGF, VEGF-R and PDGF systems for angiogenesis; the EGFR, HER2/neu, Bcr/Abl for growth control and differentiation; the intrinsic and extrinsic pathways for apoptosis; and the integrin and metalloproteinase systems for tissue invasion and metastasis. Capoxigem also potently inhibits COX-2-derived PGE2 production, reversing the PGE2-dependent epithelial-mesenchymal transition (EMT) process and the associated progression and metastasis of solid tumors. In pre-clinical cancer models, Capoxigem has shown superiority to compounds with similar mechanisms of action and synergy in combination with cisplatin, trastuzumab, and pemetrexed.

Capoxigem added to erlotinib therapy in a clinically relevant subset of biomarker-selected patients with advanced refractory non-small cell lung cancer significantly prolonged time to progression, progression-free survival and overall survival in a Phase II proof-of-concept study (APRiCOT-L). In clinical studies to date, Capoxigem has been well tolerated with a manageable side effect profile.

In addition to the APRiCOT-L study, a Phase II study of Capoxigem in pancreatic cancer recently completed enrollment and an investigator initiated study of Capoxigem in NSCLC in combination with chemotherapy is currently underway in the United States.

Apricoxib is also being evaluated for the treatment of inflammation-related pain. In inflammation-related pain, Capoxigem modulates the cyclooxygenase pathway, reducing the production of inflammatory prostaglandins. A large Phase IIa Proof-of-Concept and dose finding st
'/>"/>

SOURCE Tragara Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tragara Pharmaceuticals Apricoxib Reverses EMT, a Key Process for Cancer Progression and Metastasis
2. Prostate Cancer Immunotherapy Significantly Prolongs Survival in Men With Advanced Prostate Cancer
3. Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
4. Treating Depression Prolongs Life for Older People with Diabetes
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Bayers Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone
7. Novartis Drug Gleevec® Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
8. Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate)
9. Dendreon Announces Exercise and Closing of Overallotment Option
10. Pharmasset Announces Exercise of Underwriters Overallotment Option
11. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014 Marken announced today ... facilities to meet the clinical trial logistics growth in ... newly expanded facility will continue to serve as a ... to and from the region, and will provide additional ... Marken will combine its office and warehouse into a ...
(Date:7/31/2014)... 2014 De Pfizer Clinical Research Unit (PCRU) ... vrijwilligers van Japanse komaf voor medewerking aan klinisch onderzoek. ... is één van twee onderzoekseenheden van Pfizer , ... verbeteren door de ontdekking en ontwikkeling van nieuwe medicijnen. ... naar mannen en vrouwen van Japanse komaf – leeftijd ...
(Date:7/30/2014)... , July 30, 2014  Cepheid (Nasdaq: ... purchasing contract with Premier will end on September ... GPO will be able to continue their relationship ... HPA, MedAssets, Novation, and ROi, in addition to ... with Cepheid. "Cepheid has always recognized ...
Breaking Medicine Technology:Marken Expands Miami Regional Logistics Center 2Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 ... healthcare providers, strives in maintaining the highest standards ... That is why Healthpointe is offering Occupational ... surrounding employers, employees and patients. They also accept ... carriers. , Healthpointe’s Occupational Medicine services include, but ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 FORT ... Holdings Inc. a leading US Joint Commission Accredited ... most innovative and technologically advanced consumer storage and ... teleradiology leader is providing valued members the use ... the extraordinary services already offered by SecondOpinions.com®. ...
(Date:7/31/2014)... New York, NY (PRWEB) July 31, 2014 ... will host its first-ever event in New York on ... Eventi Hotel in Manhattan. , Featuring keynotes by ... Assemblyman Steve Katz (R-Yorktown), the event will include lunch ... Compassionate Care Act and the work NCIA is doing ...
(Date:7/31/2014)... Cheerag D. Upadhyaya has ... at the Saint Luke’s Marion Bloch Neuroscience Institute ... of spine surgery. He comes to SLMBNI from the ... has been recognized for his excellent work, research and ... addition to the Saint Luke’s Marion Bloch Neuroscience Institute ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 Recognizing ... International Plant-based Nutrition Healthcare Conference announced today ... enrolled in studies of medicine or a healthcare-related field, ... advantage of special student-only discounts for the conference, scheduled ... the Loews Coronado Bay Resort. , “As ...
Breaking Medicine News(10 mins):Health News:Occupational Medicine Services Available at Healthpointe’s Perris Facility 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 3Health News:THURSDAY, AUG 7: First-Ever National Cannabis Industry Association Event in New York Will Feature Senator Savino, Assemblyman Katz, & Industry Leaders 2Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 2Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 3Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 4Health News:Student Discounts Offered for International Plant-based Nutrition Healthcare Conference 2Health News:Student Discounts Offered for International Plant-based Nutrition Healthcare Conference 3
... 23 /PRNewswire/ -- According to a recent Consumer Reports ... failed to fill a prescription or shared a prescription in order ... struggling to cope with the rising cost of healthcare, a new ... drug costs, at no cost to consumers. , , Medtipster ...
... customers to reach ARRA criteria , , NASHVILLE, ... Inc.(R) (HMS) is pleased to announce that ... deployment to all customers. The new release features many ... in improving the patient care experience and expands upon ...
... LAUDERDALE, Fla., June 23 MEDmarketplace.com announced ... MedAssets Supply Chain Systems, effective June 1, 2009. ... buying and selling of unused and excess medical equipment. ... customers, including 1,800 hospital and IDN facilities and non ...
... Ochsner Medical Center ... , , NEW ORLEANS, June 23 /PRNewswire/ ... that California resident and Founder/CEO of Apple, Inc., Steve Jobs, has brought ... waiting lists in other states. New Orleans-based Ochsner Medical Center, which ...
... June 23 Former Chief Counsel on the Judiciary Committee ... Americans United for Life (AUL) as Of ... through its efforts to counter the confirmation of U.S. Supreme ... AUL President & CEO said: "I am very pleased to ...
... the most frequent congenital abnormality of the small bowel ... usually asymptomatic but approximately 4% are symptomatic with complications ... et al presents a case of Meckel,s diverticulum masked ... Their foundings will be published on June 14, 2009 ...
Cached Medicine News:Health News:New Online Company Is Helping to Bring a Solution to the Increasingly Devastating Problem of Healthcare Costs in America, at No Cost to Consumers 2Health News:Largest Software Release in HMS History Now Generally Available 2Health News:MedAssets Awards MEDmarketplace.com Contract for Idle Capital Equipment, Hospital Equipment and Supplies 2Health News:Organ Transplant Waiting Lists Not Limited to In-State Residents...Steve Jobs' Liver Transplant Showcases Travel Option for Organ Transplant 2Health News:Mary Harned Joins Americans United for Life, Set to Oppose Sotomayor Confirmation 2
... The primary objective of the BioPro Toe ... that will relieve pain and restore motion ... foot undisturbed. The procedure used to implant ... bone resection. , ,The design for the ...
... Electrodes provide direct cranial nerve monitoring ... circumferential design provides sensitive contact on ... real-time recordings. This unique approach provides ... removal of acoustic neuromas, microvascular decompressions, ...
... Ad-Techs Intraoperative Electrodes share similar ... The main difference is that ... are numbered to assist you ... are designed for use with ...
... As with all of Ad-Techs products, our Sphenoidal ... quality. They are available in stainless steel or ... or 2.75 inch (70 mm) long, 21 gauge ... electrodes are supplied as kits or sets. You ...
Medicine Products: